Elevation Wealth Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.8K Buy
758
+439
+138% +$34.8K 0.02% 353
2026
Q2
$25.2K Buy
319
+305
+2,179% +$25.9K 0.01% 508
2026
Q1
$1.21K Buy
14
+10
+250% +$898 ﹤0.01% 978
2025
Q4
$350 Hold
4
– – ﹤0.01% 924
2025
Q3
$230 Buy
+4
New +$230 ﹤0.01% 852
2024
Q3
– Sell
-35
Closed -$2.4K – 508
2024
Q2
$2.4K Buy
+35
New +$2.09K ﹤0.01% 443

Other funds holding GMED

Elevation Wealth Partners's GMED Position: Q3 2026 in Review

Elevation Wealth Partners increased its Globus Medical (GMED) stake by 138% in Q3 2026, buying an estimated $34.8K and bringing the position to 758 shares worth $56.8K. The position accounts for 0.02% of the portfolio, ranked #353.

Elevation Wealth Partners first reported a position in GMED in Q2 2024 and has held it in 6 quarters since. 295 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Elevation Wealth Partners held 758 shares of Globus Medical worth $56.8K as of Q3 2026.
  • Elevation Wealth Partners bought 439 Globus Medical shares in Q3 2026, an estimated $34.8K.
  • Globus Medical made up 0.02% of Elevation Wealth Partners's portfolio in Q3 2026, its #353 holding.
  • Elevation Wealth Partners first reported a position in Globus Medical in Q2 2024 and has held it in 6 quarters since.
  • 295 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.